Plantar Warts (Verruca Plantaris)

Plantar warts (verruca plantaris) are HPV infections of the keratinocytes of the sole, most often caused by HPV type 1, followed by types 2, 3, 4, 27, and 57.^[1] What sets them apart clinically is not the virus but the location: the constant axial load of body weight on the sole pushes the wart inward rather than letting it project outward, producing a flatter, thickened, callus-like plaque that hides most of its true depth beneath a compacted keratotic cap — the opposite growth pattern from the papilliform, outward-projecting texture of a common wart on the hand, finger, or knee (covered in its own chapter). This endophytic growth is also why plantar warts are so often mistaken for an ordinary corn or callus at a glance, and why they tend to be disproportionately painful for their visible size — the compressed lesion sits directly under a weight-bearing point and is compounded by friction with every step.^[1]

Natural history also differs from common warts in a way that matters for counselling: in the primary-care trial underlying the Canadian Family Physician evidence review this chapter draws on, no patient older than 12 years experienced spontaneous resolution of a plantar wart during the study period, and cryotherapy and salicylic acid performed comparably for plantar warts specifically (cryotherapy cured 30%, salicylic acid 33%, no treatment 23%, at 13 weeks) rather than cryotherapy showing the clearer advantage it does for warts elsewhere on the body.^[2] In practice, this means watchful waiting is a less reliably rewarding strategy here than for a common wart, and active treatment for a plantar wart generally needs to be more intensive — higher-concentration or occluded salicylic acid, more aggressive and more frequently repeated cryotherapy — simply to get through the thicker skin of the sole. The single highest-value screening question before recommending anything, though, is not about the wart at all: does this patient have diabetes, peripheral neuropathy, or peripheral arterial disease, since self-treatment of any foot lesion in that population carries a real risk of an unnoticed injury progressing to ulceration or infection (see Red Flags/Refer).^[3]

Typical appearance

A plantar wart presents as a sharply demarcated, thickened, roughened plaque on the sole, often appearing deceptively flat and callus-like at first glance because the pressure of standing and walking pushes it into the skin rather than allowing it to project outward. Two findings on gentle paring confirm the diagnosis and separate it from a callus: the wart interrupts and deviates the normal dermatoglyphic skin lines running across the sole, and paring reveals small red-black puncta — thrombosed, dilated dermal capillaries, the same "seeds" seen in warts elsewhere — which characteristically produce pinpoint bleeding when pared, a finding that on its own reliably distinguishes a plantar wart from a corn or callus, which pares down to a smooth, bloodless keratin plug instead.^[4] Plantar warts are frequently described by patients as feeling like there is a small stone lodged in the shoe at the affected spot, and direct palpation — pressing straight down onto the lesion — reproduces the pain, since compression and the friction of ambulation are what drive the discomfort.^[1]

Plantar warts on the sole, showing the thickened, callus-like plaque typical of the pressure-driven inward growth pattern — easily mistaken for an ordinary callus until pared. (Węgrowski, CC BY-SA 4.0, Wikimedia Commons)

Mosaic warts

When several plantar warts, typically caused by HPV type 2, coalesce into a single closely grouped plaque, the result is a mosaic wart — a larger, confluent area rather than one discrete lesion, generally more resistant to treatment and more likely to cause significant pain across a broader area of the sole than a single plantar wart would.^[4] Mosaic warts are also more likely to recur after destructive treatment, including after surgical removal, since residual virus at the margin of a large treated area can seed new adjacent lesions.

A mosaic plantar wart cluster, including regrowth at the site of a prior surgical excision — illustrating both the coalescing mosaic pattern and the genuine recurrence risk of destructive plantar-wart surgery discussed in Choose Initial Treatment. (Marionette, CC BY-SA 3.0, Wikimedia Commons)

Where they occur

Plantar warts occur at weight-bearing points — the metatarsal heads, the heel, and the plantar surface of the toes — as well as at non-weight-bearing sites on the sole where they are simply less likely to cause pain despite being present. A wart at a weight-bearing point is typically more symptomatic and more likely to prompt a visit than one tucked into the arch.

• Barefoot exposure to damp communal surfaces — locker rooms, public pool decks, and communal showers — where HPV survives on wet flooring and gains entry through skin that is macerated or has minor breaks from that same moisture.
• Participation in activities where bare feet are routine: swimming, gym and fitness-centre use, and contact sports such as wrestling.
• Adolescents and young adults have the highest incidence, but unlike common warts, spontaneous resolution of a plantar wart becomes markedly less likely with age — essentially absent past age 12 in the trial data this chapter draws on — so age alone should not be read as reassurance that a plantar wart will simply go away.^[2]
• An existing callus at a pressure point can mask an early, small plantar wart underneath it, delaying recognition until the lesion is more established and more symptomatic.
• Immunosuppression (solid-organ transplant, HIV, other cellular immunodeficiency) — as with warts elsewhere, associated with more numerous, more extensive, and more treatment-refractory disease; see the Common Warts chapter for the shared underlying mechanism.
• Occupations or activities involving prolonged standing, walking, or running, which increase both plantar pressure and the friction that makes an established wart symptomatic.
• A personal history of plantar warts, or ongoing autoinoculation from an untreated lesion elsewhere on the same foot.

History

• Barefoot exposure — locker rooms, pool decks, communal showers, contact sports — and duration and growth pattern of the lesion(s).
• Screen explicitly for diabetes, peripheral neuropathy, and peripheral arterial disease before recommending any self-care or self-debridement — this determines the entire management pathway (see Red Flags/Refer).
• Prior treatment: which product or procedure, how it was applied (was the surface pared first, and how aggressively?), and for how long, since an incomplete or too-gentle trial is a common reason a plantar lesion looks like a "treatment failure" when it has simply never received a regimen intense enough for the sole's thicker skin.
• Pain characteristics, using the same bedside maneuver detailed fully in the Corns and Calluses chapter's comparison table: pain reproduced by direct, straight-down pressure onto the lesion points toward a plantar wart, while pain reproduced by squeezing the lesion from side to side (lateral compression) points toward a corn instead — the opposite pattern from what many clinicians instinctively expect, and worth restating here from the wart side of that same distinction.
• Functional impact — is the lesion changing how the patient walks or bears weight, and for how long has that been the case.

Examination

Gently pare the surface and confirm the 2 findings described in Recognize the Condition: interrupted skin lines and pinpoint bleeding from thrombosed capillary puncta, distinguishing a plantar wart from the continuous skin lines and bloodless keratin core of a corn or callus.^[4] Note whether the presentation is a single discrete lesion or a coalescing mosaic plaque, and note its position relative to the weight-bearing points of the sole (metatarsal heads, heel, plantar toe surfaces), which affects both symptom severity and offloading strategy.

Differential diagnosis

Most classic plantar warts are diagnosed clinically on the pare-test findings above without further testing. Reserve biopsy for a lesion that is atypical, pigmented, rapidly changing, or that has genuinely failed an adequate course of destructive therapy — persistence through adequate treatment is itself a diagnostic red flag, not just a treatment-intensity problem.

• Set expectations correctly from the first visit: plantar warts are less likely to resolve spontaneously than warts elsewhere, especially past childhood, so active treatment is a reasonable default recommendation rather than a fallback.^[2]
• Match treatment intensity to the sole's thicker skin — a regimen borrowed unmodified from a hand or knee wart is a common, avoidable reason for apparent treatment failure here.
• Relieve pain and pressure and preserve normal weight-bearing and gait during treatment.
• Screen every patient for diabetes, peripheral neuropathy, and peripheral arterial disease before recommending any self-care or self-debridement, and route that population to professional foot care instead.
• Limit spread within the same foot (autoinoculation, mosaic formation) and to other people through communal barefoot exposure.
• Minimize scarring, particularly with refractory destructive options — a surgical scar at a weight-bearing point on the sole can itself become a new, permanent source of pain, unlike a scar on the hand or knee.
• Recognize early when a lesion needs to move beyond self-care: diagnostic uncertainty, an atypical or non-responding "wart," or a patient whose foot status makes self-treatment unsafe regardless of the lesion itself.

• Wear sandals or water shoes in locker rooms, on pool decks, and in communal showers while a plantar wart is active, both to avoid spreading the virus to others on shared wet surfaces and to reduce the chance of seeding a new lesion elsewhere on the same foot.
• Do not pick or scratch at a plantar wart, and do not share pumice stones, emery boards, nail files, or towels — the same autoinoculation and transmission principles that apply to common warts apply here, with the added risk that a plantar lesion is already at a friction-prone, weight-bearing site.
• Offload the lesion with a donut-shaped foam or felt pad (a hole cut to surround the wart) or a cushioned insole during active treatment, which reduces pain from day-to-day pressure and friction while the wart is being treated — the same principle used for corns and calluses, applied here to reduce discomfort during an active infection rather than to correct a mechanical cause.
• Pare down the thickened surface regularly with a pumice stone or emery board (kept separate from any file used on normal nails or skin) between active-treatment applications — this alone improves comfort and, unlike with a corn or callus, is also part of what makes concurrent salicylic acid or cryotherapy actually penetrate the sole's thicker skin.
• Duct tape occlusion has the same genuinely mixed evidence base described in the Common Warts chapter, but for plantar warts specifically it is more often used as an occlusive adjunct layered on top of salicylic acid — to help keep a higher-concentration product in prolonged contact with thick plantar skin — than as a stand-alone therapy; be honest with patients that the evidence for benefit beyond that adjunct role is inconsistent.
• Set the treatment timeline explicitly and generously: plantar warts often take longer to clear than a comparable common wart given the intensity of treatment required, and premature discontinuation before a full 6-12 week course (or longer) is a common, avoidable reason for apparent failure.

Diabetes, peripheral neuropathy, and peripheral arterial disease

Pediatrics

Children and adolescents have the highest incidence of plantar warts, and salicylic acid is generally preferred for young children because it can be applied at home by a caregiver without the pain of cryotherapy. Because plantar treatment typically needs to be more aggressive than for a common wart — deeper paring, more intense or repeated freezing — cantharidin's painless in-office application is a particularly useful refractory option specifically for young children who cannot tolerate an intensified cryotherapy protocol on a weight-bearing area.

Pregnancy and breastfeeding

Athletes and on-foot occupations

Plantar warts disproportionately affect people who are barefoot in communal wet spaces (swimmers, wrestlers, gym users) and people on their feet for long stretches at a time. Blistering from cryotherapy or the delayed blister from cantharidin can genuinely interfere with training, competition, or a physically demanding job for several days — worth discussing explicitly when timing treatment, rather than leaving a patient surprised by a painful blister before an event.

Immunocompromised patients

As with warts elsewhere, transplant recipients, patients with HIV, and others with cellular immunodeficiency develop more numerous, more extensive, and more treatment-refractory plantar and mosaic warts, and conventional first-line therapy is less reliably effective. Treat actively and use a lower threshold to refer early for dermatology- or podiatry-directed combination therapy rather than working through a prolonged standard OTC trial first.

Older adults

Age-related thinning of the protective plantar fat pad increases pressure-related pain from any plantar lesion, including a wart, and a painful plantar lesion that changes gait carries a real fall risk in this group — the same consideration the Corns and Calluses chapter raises for that condition applies equally here. Screen carefully for diabetes, neuropathy, and peripheral arterial disease before recommending self-care, since these are also more prevalent with advancing age.

Reassess a salicylic acid course at the end of a full 6-12 week trial, and expect that a plantar course may reasonably run longer than that for a common wart given the intensity of paring and occlusion required. At follow-up, confirm the patient has actually been paring aggressively to pinpoint bleeding before each application and maintaining occlusion, since a technique borrowed from a common-wart regimen (light paring, no occlusion) is a common reason for an apparent plateau here.

For a patient undergoing cryotherapy, review response and tolerability every 1-3 weeks, and confirm the freeze-thaw-freeze technique and pre-treatment paring are actually being used — a single light freeze without paring first under-treats a plantar wart relative to warts elsewhere.^[4] Watch specifically for excessive blistering that is genuinely impairing weight-bearing or gait, which may call for a less aggressive interval or additional offloading between sessions.

For patients with diabetes, peripheral neuropathy, or peripheral arterial disease, there is no self-monitoring plan — confirm at follow-up contact that the patient has actually been seen by a foot care specialist rather than continuing to watch a lesion at home.^[3]

At every visit, reinforce footwear-in-communal-areas counselling (sandals in locker rooms, pool decks, communal showers) to prevent both spread to others and reinfection or new lesion formation on the same foot.

1. Confirm the diagnosis is genuinely a plantar wart and not a mimic (see Assessment/Diagnosis) — a persistent lesion that "fails" treatment is sometimes a corn, a plantar fibroma, or, in a longstanding treatment-resistant single lesion, a reason to consider verrucous carcinoma or acral melanoma rather than simply escalating destructive therapy further.
2. Confirm treatment intensity and technique before concluding a therapy has failed: was the surface pared aggressively to pinpoint bleeding before each salicylic acid application, was occlusion actually maintained, and for cryotherapy, was the freeze-thaw-freeze technique used after pre-treatment paring — a regimen intense enough for a common wart is often simply not intense enough for the sole.^[4]
3. If salicylic acid alone has been used adherently at an appropriately aggressive intensity without adequate response, add or switch to cryotherapy, or combine the two.
4. If an adequate, appropriately intense trial of salicylic acid and/or cryotherapy has genuinely failed, refer for cantharidin, contact immunotherapy, or laser therapy before considering surgery, given the plantar-specific scarring and recurrence risk of curettage, cautery, or excision.^[4]
5. At any point where the lesion is atypical, pigmented, enlarging, or has persisted through genuinely adequate refractory treatment — stop empiric wart treatment and pursue biopsy rather than escalating to surgery.
6. Re-screen for diabetes, peripheral neuropathy, and peripheral arterial disease if this was not already established, and refer promptly rather than continuing self-care if any is present.^[3]

• Treating a plantar wart with a common-wart-intensity regimen — light daily salicylic acid with no occlusion, or a single gentle cryotherapy freeze with no pre-treatment paring — and concluding the drug failed when the real problem was under-treatment for the sole's thicker skin.
• Recommending salicylic acid or self-debridement to a patient with diabetes, peripheral neuropathy, or peripheral arterial disease without screening for these conditions first.^[3]
• Assuming cryotherapy is clearly the more effective option here the way it can be for common warts elsewhere — the plantar-specific trial data show salicylic acid performing at least as well.^[2]
• Confusing a plantar wart for a corn or callus (or vice versa) without checking skin-line continuity, pinpoint bleeding on paring, and the direct-pressure-versus-lateral-pinch pain distinction detailed in the Corns and Calluses chapter.
• Treating a longstanding, single, enlarging, or treatment-resistant "plantar wart" indefinitely with repeated destructive therapy rather than considering verrucous carcinoma or acral melanoma and pursuing biopsy.
• Reaching for surgical excision or curettage as an early refractory option without discussing the plantar-specific scarring and recurrence risk, and the possibility that the resulting scar itself becomes a new source of weight-bearing pain.
• Endorsing unsupervised home "bathroom surgery" with a blade — genuinely more dangerous on a weight-bearing, friction-prone area than elsewhere on the body.
• Not counselling on footwear in communal wet areas alongside whichever active treatment is chosen, leaving an ongoing source of reinfection or transmission unaddressed.

How to use this table: Doses are adult doses and require patient-specific confirmation (renal/hepatic function, weight, allergy history). Pediatric dosing is weight-based per the current product monograph unless stated. Drug pricing is intentionally omitted. Select any drug name to open its complete Pharmasist Drug Database page.

Keratolytics (Topical, Self-Applied)

First-line active treatment for most plantar warts. Requires more aggressive paring (to pinpoint bleeding) and typically longer occlusion than the same product used for a common wart elsewhere on the body, given the thickness of plantar skin.

Cryotherapy

For plantar warts, cure rates with salicylic acid at least match cryotherapy — unlike warts elsewhere on the body, where cryotherapy tends to have the edge. A more aggressive freeze protocol than for a common wart is typically needed.

Office-Administered / Specialist Refractory-Wart Therapies

Reserve for plantar warts that have not responded to an adequately intense, adherent trial of salicylic acid and/or cryotherapy. Favour the lower-scarring options before considering surgery, given the plantar-specific scarring and recurrence risk described in Choose Initial Treatment.